Chronic Liver Disease

Chronic liver disease is a progressive loss of liver functions for a period longer than 6 months. Chronic liver disease is caused by inflammation and destruction of liver cells that ultimately causes a hardening (fibrosis) and scarring (cirrhosis) of the liver.

Quick Answer

What it is

Chronic liver disease is a progressive loss of liver functions for a period longer than 6 months. Chronic liver disease is caused by inflammation and destruction of liver cells that ultimately causes a hardening (fibrosis) and scarring (cirrhosis) of the liver.

Key findings

  • Grade C: Liver Cell Content (TUDCA)
  • Grade D: Bilirubin (S-adenosylmethionine)
  • Grade D: All-Cause Mortality (Vitamin D)

Safety

No specific caution or interaction language was detected in the current summary/outcome notes.

â„šī¸ Quick Facts

Quick Facts: Chronic Liver Disease

  • Supplements Studied:4
  • Research Trials:1
  • Total Participants:7,066
  • Top Supplement:TUDCA (C)
1 trials
7,066 ppts
4 supps ¡ 17 outcomes

Evidence-Based Protocol

Supplement stack ranked by research quality

Moderate Evidence

Primary Stack (Tier 1)

Restores glutathione levels and supports hepatocyte membrane integrity

30 studies | 6,937 participants

Supporting Stack (Tier 2)

10mcg daily

Supports chronic liver disease through multiple complementary pathways

132 studies | 65,344 participants

Supports chronic liver disease through multiple complementary pathways

30 studies | 6,937 participants
1mg daily

Supports chronic liver disease through multiple complementary pathways

40 studies | 1,844 participants
500mg daily

Reduces endoplasmic reticulum stress and protects against bile acid toxicity

4 studies | 20 participants

How It Works

This supplement protocol targets multiple biological pathways, which plays a central role in overall health and wellbeing. When this pathway functions optimally, the body maintains better chronic liver disease outcomes through improved cellular signaling and reduced physiological stress. Liver health requires proper detoxification capacity, bile production, and protection from oxidative damage.

s-adenosylmethionine serves as the foundation of this protocol. It restores glutathione levels and supports hepatocyte membrane integrity. Vitamin D complements this approach by supports chronic liver disease through multiple complementary pathways. S-adenosylmethionine complements this approach by supports chronic liver disease through multiple complementary pathways. Resveratrol complements this approach by supports chronic liver disease through multiple complementary pathways.

Good clinical evidence supports this combination approach. By addressing multiple points along the multiple pathway, these supplements work synergistically to produce better results than any single intervention alone. The combined effect helps restore balance to systems that become dysregulated in chronic liver disease.

Rather than masking symptoms like conventional medications, these natural compounds support your body's intrinsic healing mechanisms and regulatory systems.

Initial improvements may be noticed within 4-6 weeks, with continued benefits developing over 2-3 months. Consistency is key. For best results, take with meals to enhance absorption unless otherwise directed and maintain regular daily use.

Generated from peer-reviewed researchSchema v

Detailed Outcomes

|
C
Liver Cell Content
Small Increase
1 study
small↑Improves
?
Liver Enzymes
1 study
↑Worsens
D
Bilirubin
No effect
5 studies
none
?
Depression Symptoms
11 studies
↓Improves
?
Liver Enzymes
6 studies
↑Worsens
?
Itching
5 studies
↑Improves
?
Osteoarthritis Symptoms
3 studies
↓Improves
D
Bilirubin
No effect
5 studies
none
?
Liver Enzymes
15 studies
↑Worsens
D
All-Cause Mortality
No effect
4 studies
none
?
High-density lipoprotein (HDL)
15 studies
↑Improves
?
Insulin Resistance
15 studies
↓Improves
?
Triglycerides
14 studies
↓Improves
?
Insulin
11 studies
↑Worsens
?
Liver Fat
3 studies
↓Improves
?
Liver Fibrosis
3 studies
↓Improves
?
Liver Enzymes
1 study
↑Worsens

Related Conditions

Metabolic Health

4 shared supplements ¡ 975 outcomes

Research on metabolism, blood glucose regulation, insulin sensitivity, and metabolic syndrome.

4 shared supplements ¡ outcomes

Osteoarthritis (OA)

3 shared supplements ¡ 116 outcomes

Osteoarthritis (OA) is a joint disease involving cartilage degradation. It’s not clear what exactly causes OA, but some risk factors include joint injury, overweight or obesity, aging, misaligned joints, and family history. Lots of supplements have been studied in people with OA, as have lifestyle interventions including weight loss and exercise.

Obesity

3 shared supplements ¡ 525 outcomes

Obesity is a condition of excessive body fat that increases the risk for other conditions such as diabetes and heart disease. Fat is how the body stores extra calories that were eaten but not used. Obesity treatment usually involves restricting the calories eaten or creating a negative calorie balance.

Nonalcoholic Fatty Liver Disease (NAFLD)

3 shared supplements ¡ 221 outcomes

Non-alcoholic fatty liver disease (NAFLD) is a condition in which excessive fat (more than 5% of liver weight) accumulates in the liver due to causes unrelated to alcohol.

Upper Respiratory Tract Infection

2 shared supplements ¡ 49 outcomes

Upper respiratory tract infection refers to many different infections that can occur in the upper airways, with the common cold being just one type. These infections can cause inflammation and irritation in areas like the larynx, pharynx, nose, sinuses, and nostrils.

Type 2 Diabetes

2 shared supplements ¡ 868 outcomes

Type 2 diabetes (T2D) is a disease in which blood glucose levels are too high. It is characterized by insulin resistance in muscle, fat, and pancreas cells and an inability of the pancreas to manufacture enough insulin to control blood glucose levels. T2D is strongly associated with excess body fat, and weight loss induced by lifestyle changes is extremely effective for treating T2D.

Type 1 Diabetes

2 shared supplements ¡ 76 outcomes

Type 1 diabetes is an autoimmune disease in which the pancreas stops producing insulin. It can begin at any age, although most commonly in childhood or adolescence, and requires life-long treatment with insulin.